Instil Bio (TIL) has announced the appointment of Jamie Freedman as Chief Medical Officer.  Jamie Freedman is a Hematologist-Oncologist and a highly experienced biopharmaceutical executive.

A new avenue for targeted drug delivery has been proposed by researchers from The Grainger College of Engineering at the ...

Jean Fallacara isn’t just done with biohacking; he’s declared it over. After more than two decades of experimenting with every gadget, protocol and peptide under the sun, he sold his last venture in ...

In biomedical research, so-called organs-on-a-chip, also referred to as microphysiological systems, are becoming increasingly ...

Sanofi completes acquisition of DR-0201 Paris, May 27, 2025. Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private c ...